Surgeons’ Dilemma: Treatment of Implant-Associated Infection in the Cosmetic Breast Augmentation Patient
- 336 Downloads
Augmentation mammaplasty is the most common plastic surgical procedure performed in the USA. The management of severe implant-associated infection is a challenge, and the traditional two-stage treatment is associated with significant limitations. The aim of this literature review is to provide a comprehensive analysis of all studies dealing with the management of severe infection or implant exposure following cosmetic breast augmentation.
The PubMed and Cochrane databases were searched through February 2018 for studies on the management of severe infection and threatened or actual implant exposure following primary augmentation mammaplasty. Search terms used were “breast implant,” “breast prosthesis,” “breast augmentation,” “breast augmentation complications,” “infected implant,” “implant salvage” and “implant exposure.”
Five articles met inclusion criteria. There was inconsistency in the reporting of several key factors, such as the antibiotic regimens employed, culture sensitivities, time from diagnosis to treatment, implant characteristics, as well as the precise treatment of the capsule and pocket. A total of 58 implants were treated, of which 37 (63.8%) were exposed in the setting of infection and 21 (36.2%) were infected without exposure. One-stage implant salvage was employed in 31 implants and was successful in all. The capsular contracture rate with this approach was 6.5%. Antibiotic-alone, non-operative treatment was employed in the salvage of 22 implants, with success and capsular contracture rates of 77.3 and 13.6%, respectively. In the setting of severe periprosthetic infection in the absence of implant exposure, antibiotic-alone treatment was successful in the salvage of 13 out of 14 implants (92.9%).
The inconsistency and paucity of the data in the literature preclude definitive conclusions with regard to the optimal management of the threatened implant following augmentation mammaplasty. Given the excellent salvage rates in this setting, a more prominent role and liberal utilization of implant salvage are proposed.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
KeywordsBreast augmentation Implant salvage Implant-associated infection Literature review
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflicts of interest to disclose. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study informed consent is not required.
- 1.American Society of Plastic Surgeons. 2017 Cosmetic plastic surgery statistics. https://www.plasticsurgery.org/documents/News/Statistics/2017/plastic-surgery-statistics-report-2017.pdf. Accessed 23 April 2018
- 11.Azouz V, Mirhaidari S, Wagner DS (2018) Defining infection in breast reconstruction: a literature review. Ann Plast Surg 80(5):587–591Google Scholar